In the BioHarmony Drug Report Database
Tinzaparin
Innohep (tinzaparin sodium) is an oligosaccharide pharmaceutical. Tinzaparin sodium was first approved as Innohep on 2000-07-14. It is used to treat pulmonary embolism, thromboembolism, and venous thrombosis in the USA. It has been approved in Europe to treat venous thromboembolism. The pharmaceutical is active against antithrombin-III.
Trade Name
|
Innohep |
|---|---|
Common Name
|
tinzaparin sodium |
ChEMBL ID
|
CHEMBL1201414 |
Indication
|
pulmonary embolism, thromboembolism, venous thromboembolism, venous thrombosis |
Drug Class
|
Heparin derivatives and low molecular weight (or depolymerized) heparins |
Image (chem structure or protein)
